Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 53

1.

(Sample) size matters! An examination of sample size from the SPRINT trial study to prospectively evaluate reamed intramedullary nails in patients with tibial fractures.

SPRINT Investigators, Bhandari M, Tornetta P 3rd, Rampersad SA, Sprague S, Heels-Ansdell D, Sanders DW, Schemitsch EH, Swiontkowski M, Walter S.

J Orthop Trauma. 2013 Apr;27(4):183-8. doi: 10.1097/BOT.0b013e3182647e0e.

PMID:
23525086
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Prognostic factors for predicting outcomes after intramedullary nailing of the tibia.

Schemitsch EH, Bhandari M, Guyatt G, Sanders DW, Swiontkowski M, Tornetta P, Walter SD, Zdero R, Goslings JC, Teague D, Jeray K, McKee MD; Study to Prospectively Evaluate Reamed Intramedullary Nails in Patients with Tibial Fractures (SPRINT) Investigators.

J Bone Joint Surg Am. 2012 Oct 3;94(19):1786-93. doi: 10.2106/JBJS.J.01418.

PMID:
23032589
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Development and validation of an instrument to predict functional recovery in tibial fracture patients: the Somatic Pre-Occupation and Coping (SPOC) questionnaire.

Busse JW, Bhandari M, Guyatt GH, Heels-Ansdell D, Kulkarni AV, Mandel S, Sanders D, Schemitsch E, Swiontkowski M, Tornetta P 3rd, Wai E, Walter SD; SPRINT Investigators & the Medically Unexplained Syndromes Study Group.

J Orthop Trauma. 2012 Jun;26(6):370-8. doi: 10.1097/BOT.0b013e31822421e2.

PMID:
22011635
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Outcomes assessment in the SPRINT multicenter tibial fracture trial: Adjudication committee size has trivial effect on trial results.

SPRINT Investigators, Simunovic N, Walter S, Devereaux PJ, Sprague S, Guyatt GH, Schemitsch E, Tornetta P 3rd, Sanders D, Swiontkowski M, Bhandari M.

J Clin Epidemiol. 2011 Sep;64(9):1023-33. doi: 10.1016/j.jclinepi.2010.12.007. Epub 2011 Mar 25.

PMID:
21439784
[PubMed - indexed for MEDLINE]
5.

Use of both Short Musculoskeletal Function Assessment questionnaire and Short Form-36 among tibial-fracture patients was redundant.

Busse JW, Bhandari M, Guyatt GH, Heels-Ansdell D, Mandel S, Sanders D, Schemitsch E, Swiontkowski M, Tornetta P 3rd, Wai E, Walter SD; SPRINT Investigators.

J Clin Epidemiol. 2009 Nov;62(11):1210-7. doi: 10.1016/j.jclinepi.2009.01.014. Epub 2009 Apr 11.

PMID:
19364637
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Synthesis of (-)-PNU-286607 by asymmetric cyclization of alkylidene barbiturates.

Ruble JC, Hurd AR, Johnson TA, Sherry DA, Barbachyn MR, Toogood PL, Bundy GL, Graber DR, Kamilar GM.

J Am Chem Soc. 2009 Mar 25;131(11):3991-7. doi: 10.1021/ja808014h.

PMID:
19260642
[PubMed - indexed for MEDLINE]
7.

Randomized trial of reamed and unreamed intramedullary nailing of tibial shaft fractures.

Study to Prospectively Evaluate Reamed Intramedullary Nails in Patients with Tibial Fractures Investigators, Bhandari M, Guyatt G, Tornetta P 3rd, Schemitsch EH, Swiontkowski M, Sanders D, Walter SD.

J Bone Joint Surg Am. 2008 Dec;90(12):2567-78. doi: 10.2106/JBJS.G.01694.

PMID:
19047701
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Discovery and characterization of QPT-1, the progenitor of a new class of bacterial topoisomerase inhibitors.

Miller AA, Bundy GL, Mott JE, Skepner JE, Boyle TP, Harris DW, Hromockyj AE, Marotti KR, Zurenko GE, Munzner JB, Sweeney MT, Bammert GF, Hamel JC, Ford CW, Zhong WZ, Graber DR, Martin GE, Han F, Dolak LA, Seest EP, Ruble JC, Kamilar GM, Palmer JR, Banitt LS, Hurd AR, Barbachyn MR.

Antimicrob Agents Chemother. 2008 Aug;52(8):2806-12. doi: 10.1128/AAC.00247-08. Epub 2008 Jun 2.

PMID:
18519725
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Chemical Oxidation of 2,4-Diamino-pyrrolo[2,3-d]pyrimidines.

Bundy GL, Gremban RS, Banitt LS, Palmer JR, Mizsak SA, Han F.

J Org Chem. 1998 Oct 16;63(21):7542-7546. No abstract available.

PMID:
11672414
[PubMed - as supplied by publisher]
10.

Preclinical evaluation of anti-inflammatory activities of the novel pyrrolopyrimidine PNU-142731A, a potential treatment for asthma.

Chin JE, Hatfield CA, Winterrowd GE, Krzesicki RF, Shull KL, Fidler SF, Kolbasa KP, Brashler JR, Griffin RL, Fleming WE, Justen JM, Banitt LS, Bundy GL, Richards IM.

J Pharmacol Exp Ther. 1999 Jul;290(1):188-95.

PMID:
10381775
[PubMed - indexed for MEDLINE]
Free Article
11.

Contribution of serum protein association to discrepancy between the in vivo and in vitro UDS results for 6,7-dimethyl-2,4-di-1-pyrrolidinyl-7H-pyrrolo[2,3-d]pyrimidine (U-89843).

Zhao Z, Koeplinger KA, Padbury GE, Aaron CS, Harbach PR, Mayo JK, Mattes WB, Bundy GL.

Mutat Res. 1997 Dec 12;395(2-3):119-26.

PMID:
9465922
[PubMed - indexed for MEDLINE]
12.

PNU-107484A with alpha isoform-dependent functional changes in alpha(x)beta2gamma2 subtypes of rat recombinant GABA(A) receptors.

Im HK, Im WB, Carter DB, Schwartz TM, Bundy GL, VonVoigtlander PF.

Br J Pharmacol. 1997 Nov;122(5):821-4.

PMID:
9384496
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Pyrrolopyrimidines: novel brain-penetrating antioxidants with neuroprotective activity in brain injury and ischemia models.

Hall ED, Andrus PK, Smith SL, Fleck TJ, Scherch HM, Lutzke BS, Sawada GA, Althaus JS, Vonvoigtlander PF, Padbury GE, Larson PG, Palmer JR, Bundy GL.

J Pharmacol Exp Ther. 1997 May;281(2):895-904.

PMID:
9152399
[PubMed - indexed for MEDLINE]
Free Article
14.

Bioactivation of 6,7-dimethyl-2,4-di-1-pyrrolidinyl-7H-pyrrolo[2,3-d]pyrimidine (U-89843) to reactive intermediates that bind covalently to macromolecules and produce genotoxicity.

Zhao Z, Koeplinger KA, Padbury GE, Hauer MJ, Bundy GL, Banitt LS, Schwartz TM, Zimmermann DC, Harbach PR, Mayo JK, Aaron CS.

Chem Res Toxicol. 1996 Dec;9(8):1230-9.

PMID:
8951224
[PubMed - indexed for MEDLINE]
15.

In vitro and in vivo biotransformation of 6,7-dimethyl-2,4-di-1-pyrrolidinyl-7H-pyrrolo[2,3-D]pyrimidine (U-89843) in the rat.

Zhao Z, Koeplinger KA, Bundy GL, Banitt LS, Padbury GE, Hauer MJ, Sanders PE.

Drug Metab Dispos. 1996 Feb;24(2):187-98.

PMID:
8742230
[PubMed - indexed for MEDLINE]
16.

Neuroprotective efficacy of microvascularly-localized versus brain-penetrating antioxidants.

Hall ED, Andrus PK, Smith SL, Oostveen JA, Scherch HM, Lutzke BS, Raub TJ, Sawada GA, Palmer JR, Banitt LS, Tustin JS, Belonga KL, Ayer DE, Bundy GL.

Acta Neurochir Suppl. 1996;66:107-13. Review.

PMID:
8780807
[PubMed - indexed for MEDLINE]
17.

Synthesis of novel 2,4-diaminopyrrolo-[2,3-d]pyrimidines with antioxidant, neuroprotective, and antiasthma activity.

Bundy GL, Ayer DE, Banitt LS, Belonga KL, Mizsak SA, Palmer JR, Tustin JM, Chin JE, Hall ED, Linseman KL, et al.

J Med Chem. 1995 Oct 13;38(21):4161-3. No abstract available.

PMID:
7473542
[PubMed - indexed for MEDLINE]
18.

Peptide to glycopeptide: glycosylated oligopeptide renin inhibitors with attenuated in vivo clearance properties.

Fisher JF, Harrison AW, Bundy GL, Wilkinson KF, Rush BD, Ruwart MJ.

J Med Chem. 1991 Oct;34(10):3140-3. No abstract available.

PMID:
1920364
[PubMed - indexed for MEDLINE]
19.

Exploiting the molecular template of angiotensinogen in the discovery and design of peptidyl, pseudopeptidyl and peptidimimetic inhibitors of human renin: a structure-activity perspective.

Sawyer TK, Hester JB, Schostarez HJ, Thaisrivongs S, Bundy GL, Liu L, Bradford VS, De Vaux AE, Staples DJ, Maggiora LL, et al.

Adv Exp Med Biol. 1991;306:307-23. Review. No abstract available.

PMID:
1812721
[PubMed - indexed for MEDLINE]
20.

Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophils.

Bleasdale JE, Thakur NR, Gremban RS, Bundy GL, Fitzpatrick FA, Smith RJ, Bunting S.

J Pharmacol Exp Ther. 1990 Nov;255(2):756-68.

PMID:
2147038
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk